Innate Pharma S.A. (EPA:IPH)
France · Delayed Price · Currency is EUR 1.748
+0.040 (2.34%)
At close: Nov 28, 2025
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of €161.11 million as of November 28, 2025. Its market cap has increased by 25.64% in one year.
Market Cap
161.11M
Enterprise Value
128.11M
Revenue
12.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.75
Market Cap Chart
Since November 1, 2006, Innate Pharma's market cap has increased from 792.12K to 161.11M, an increase of 20,238.80%. That is a compound annual growth rate of 32.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 161.11M | 0.73% |
| Dec 31, 2024 | 159.94M | -24.29% |
| Dec 29, 2023 | 211.24M | -19.93% |
| Dec 30, 2022 | 263.84M | -24.98% |
| Dec 31, 2021 | 351.67M | 28.64% |
| Dec 31, 2020 | 273.37M | -41.60% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 144.39B |
| Sanofi | 104.35B |
| Sartorius Stedim Biotech | 19.75B |
| bioMérieux | 12.90B |
| Eurofins Scientific SE | 10.40B |
| Ipsen | 10.22B |
| ABIVAX Société Anonyme | 8.16B |
| Virbac | 3.09B |